# Luteinizing Hormone (LH) Supplementation in Gonadotropin-releasing Hormone (GnRH) Antagonist Cycles

> **NCT01037699** · PHASE3 · COMPLETED · sponsor: **Instituto Valenciano de Infertilidad, IVI VALENCIA** · enrollment: 720 (actual)

## Conditions studied

- Ovarian Stimulation

## Interventions

- **DRUG:** rFSH: Follicle Stimulating Hormone
- **DRUG:** rFSH: Follicle Stimulating Hormone
- **DRUG:** rFSH: Follicle Stimulating Hormone and rLH: Luteinizing Hormone (Recombinant Luteotrophin alfa)
- **DRUG:** rFSH: Follicle Stimulating Hormone and rLH: Luteinizing Hormone (Recombinant Luteotrophin alfa)

## Key facts

- **NCT ID:** NCT01037699
- **Lead sponsor:** Instituto Valenciano de Infertilidad, IVI VALENCIA
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 720 (ACTUAL)
- **Last updated:** 2009-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01037699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01037699, "Luteinizing Hormone (LH) Supplementation in Gonadotropin-releasing Hormone (GnRH) Antagonist Cycles". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01037699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*